Importantly, dKO tumours downregulated markers of effector CD8+ cells, including Cd8a, Ifng and Gzmc. Overall, the transcriptomics data suggest that there is an impaired anti-tumour immune response in dKO animals. The gene discussed is CD8A; the disease is neoplasm.